Repaglinide Pellets

(Product under development)
Repaglinide PelletsRepaglinide is for the treatment of type II diabetes.

It is supplied by Novo Nordisk. In Japan, Dainippon Sumitomo pharma sells.

Repaglinide belongs to the meglitinide class of blood glucose-lowering drugs.

Available Form:
Repaglinide Pellets
Repaglinide Granules

Umang Pharmatech equipments used for production of Repaglinide Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Repaglinide Pellets
Systematic (IUPAC) Name
Repaglinide Pellets
Repaglinide Pellets
Chemical data
(S)-(+)-2-ethoxy-4-[2-(3-methyl-1-[2-(piperidin-1-yl)phenyl]butylamino)-2-oxoethyl]benzoic acid
CAS number : 135062-02-1
ATC code : A10BX02
PubChem : CID 65981
DrugBank : APRD00439
ChemSpider : 59377
UNII : 668Z8C33LU
KEGG : D00594
Formula : C27H36N2O4
Mol. mass : 452.586 g/mol

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech